A detailed history of Apollon Wealth Management, LLC transactions in Boston Scientific Corp stock. As of the latest transaction made, Apollon Wealth Management, LLC holds 18,956 shares of BSX stock, worth $1.59 Million. This represents 0.05% of its overall portfolio holdings.

Number of Shares
18,956
Previous 21,320 11.09%
Holding current value
$1.59 Million
Previous $1.46 Million 0.07%
% of portfolio
0.05%
Previous 0.05%

Shares

14 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Jul 19, 2024

SELL
$67.33 - $77.71 $159,168 - $183,706
-2,364 Reduced 11.09%
18,956 $1.46 Million
Q1 2024

May 02, 2024

BUY
$57.6 - $68.62 $34,387 - $40,966
597 Added 2.88%
21,320 $1.46 Million
Q4 2023

Feb 06, 2024

BUY
$48.64 - $57.81 $443,159 - $526,706
9,111 Added 78.46%
20,723 $1.2 Million
Q3 2023

Nov 14, 2023

SELL
$50.19 - $54.68 $68,308 - $74,419
-1,361 Reduced 10.49%
11,612 $613,000
Q2 2023

Aug 04, 2023

SELL
$49.72 - $54.64 $238,506 - $262,108
-4,797 Reduced 26.99%
12,973 $701,000
Q1 2023

May 15, 2023

BUY
$45.09 - $50.03 $82,108 - $91,104
1,821 Added 11.42%
17,770 $889,000
Q4 2022

Feb 15, 2023

SELL
$39.56 - $47.22 $40,549 - $48,400
-1,025 Reduced 6.04%
15,949 $738,000
Q3 2022

Nov 08, 2022

SELL
$36.71 - $109.66 $73 - $219
-2 Reduced 0.01%
16,974 $657,000
Q2 2022

Aug 11, 2022

SELL
$35.24 - $47.1 $46,093 - $61,606
-1,308 Reduced 7.15%
16,976 $633,000
Q1 2022

May 16, 2022

SELL
$40.9 - $45.1 $93,047 - $102,602
-2,275 Reduced 11.07%
18,284 $810,000
Q4 2021

Feb 14, 2022

BUY
$38.07 - $44.87 $332,998 - $392,477
8,747 Added 74.05%
20,559 $873,000
Q3 2021

Nov 15, 2021

BUY
$41.23 - $45.88 $487,008 - $541,934
11,812 New
11,812 $513,000
Q3 2020

Nov 03, 2020

SELL
$34.44 - $42.23 $21,869 - $26,816
-635 Closed
0 $0
Q2 2020

Aug 14, 2020

BUY
$30.19 - $39.11 $19,170 - $24,834
635 New
635 $22,000

Others Institutions Holding BSX

About BOSTON SCIENTIFIC CORP


  • Ticker BSX
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 1,431,609,984
  • Market Cap $120B
  • Description
  • Boston Scientific Corporation develops, manufactures, and markets medical devices for use in various interventional medical specialties worldwide. It operates through three segments: MedSurg, Rhythm and Neuro, and Cardiovascular. The company offers devices to diagnose and treat gastrointestinal and pulmonary conditions; devices to treat various ...
More about BSX
Track This Portfolio

Track Apollon Wealth Management, LLC Portfolio

Follow Apollon Wealth Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Apollon Wealth Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Apollon Wealth Management, LLC with notifications on news.